Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Reduced oxydised N-acetyl heparin

EU orphan designation number: EU/3/15/1487   
Active ingredient: Reduced oxydised N-acetyl heparin
Indication: Treatment of plasma cell myeloma
Sponsor: Leadiant Biosciences Ltd
21 Holborn Viaduct, London EC1A 2DY, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/05/2015 Orphan designation EMA/OD/277/14 (2015)3567 of 21/05/2015
29/06/2015 Transfer of orphan designation EMA/OD/277/14/T/01 (2015)4504 of 25/06/2015
12/01/2017 Change of name and/or address of sponsor